BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 11581002)

  • 1. Autosomal dominant neurohypophyseal diabetes insipidus in a Swiss family, caused by a novel mutation (C59Delta/A60W) in the neurophysin moiety of prepro-vasopressin-neurophysin II (AVP-NP II).
    Flück CE; Deladoëy J; Nayak S; Zeller O; Kopp P; Mullis PE
    Eur J Endocrinol; 2001 Oct; 145(4):439-44. PubMed ID: 11581002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel mutation (R97C) in the neurophysin moiety of prepro-vasopressin-neurophysin II associated with autosomal-dominant neurohypophyseal diabetes insipidus.
    Rutishauser J; Kopp P; Gaskill MB; Kotlar TJ; Robertson GL
    Mol Genet Metab; 1999 May; 67(1):89-92. PubMed ID: 10329029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel point mutation in the translation initiation codon of the pre-pro-vasopressin-neurophysin II gene: cosegregation with morphological abnormalities and clinical symptoms in autosomal dominant neurohypophyseal diabetes insipidus.
    Rutishauser J; Böni-Schnetzler M; Böni J; Wichmann W; Huisman T; Vallotton MB; Froesch ER
    J Clin Endocrinol Metab; 1996 Jan; 81(1):192-8. PubMed ID: 8550751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel splice site mutation of the arginine vasopressin-neurophysin II gene identified in a kindred with autosomal dominant familial neurohypophyseal diabetes insipidus.
    Tae HJ; Baek KH; Shim SM; Yoo SJ; Kang MI; Cha BY; Lee KW; Son HY; Kang SK
    Mol Genet Metab; 2005; 86(1-2):307-13. PubMed ID: 16006166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and molecular analysis of three families with autosomal dominant neurohypophyseal diabetes insipidus associated with a novel and recurrent mutations in the vasopressin-neurophysin II gene.
    Rutishauser J; Kopp P; Gaskill MB; Kotlar TJ; Robertson GL
    Eur J Endocrinol; 2002 May; 146(5):649-56. PubMed ID: 11980620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity in clinical manifestation of autosomal dominant neurohypophyseal diabetes insipidus caused by a mutation encoding Ala-1-->Val in the signal peptide of the arginine vasopressin/neurophysin II/copeptin precursor.
    Repaske DR; Medlej R; Gültekin EK; Krishnamani MR; Halaby G; Findling JW; Phillips JA
    J Clin Endocrinol Metab; 1997 Jan; 82(1):51-6. PubMed ID: 8989232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation of Glu78 of the AVP-NPII gene impairs neurophysin as a carrier protein for arginine vasopressin in a family with neurohypophyseal diabetes insipidus.
    Lee YW; Lee KW; Ryu JW; Mok JO; Ki CS; Park HK; Kim YJ; Kim SJ; Byun DW; Suh KI; Yoo MH; Shin HB; Lee YK; Kim CH
    Ann Clin Lab Sci; 2008; 38(1):12-4. PubMed ID: 18316776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autosomal dominant neurohypophyseal diabetes insipidus due to substitution of histidine for tyrosine(2) in the vasopressin moiety of the hormone precursor.
    Rittig S; Siggaard C; Ozata M; Yetkin I; Gregersen N; Pedersen EB; Robertson GL
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3351-5. PubMed ID: 12107248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and molecular evidence of abnormal processing and trafficking of the vasopressin preprohormone in a large kindred with familial neurohypophyseal diabetes insipidus due to a signal peptide mutation.
    Siggaard C; Rittig S; Corydon TJ; Andreasen PH; Jensen TG; Andresen BS; Robertson GL; Gregersen N; Bolund L; Pedersen EB
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2933-41. PubMed ID: 10443701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel mutation in the arginine vasopressin-neurophysin II gene affecting the sixth intrachain disulfide bridge of the neurophysin II moiety.
    Baglioni S; Corona G; Maggi M; Serio M; Peri A
    Eur J Endocrinol; 2004 Nov; 151(5):605-11. PubMed ID: 15538939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel heterozygous missense mutation in the vasopressin moiety is identified in a Japanese person with neurohypophyseal diabetes insipidus.
    Kobayashi H; Fujisawa I; Ikeda K; Son C; Iwakura T; Yoshimoto A; Kasahara M; Ishihara T; Ogawa Y
    J Endocrinol Invest; 2006 Mar; 29(3):252-6. PubMed ID: 16682840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel arginine vasopressin-neurophysin II mutation causes autosomal dominant neurohypophyseal diabetes insipidus and morphologic pituitary changes.
    Skordis N; Patsalis PC; Hettinger JA; Kontou M; Herakleous E; Krishnamani MR; Phillips JA
    Horm Res; 2000; 53(5):239-45. PubMed ID: 11150885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dilatative uropathy as a manifestation of neurohypophyseal diabetes insipidus due to a novel mutation in the arginine vasopressin-neurophysin-II gene.
    Lindenthal V; Mainberger A; Morris-Rosendahl DJ; Löning L; Mayer W; Müller HL
    Klin Padiatr; 2013 Dec; 225(7):407-12. PubMed ID: 24158882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new mutation of the arginine vasopressin-neurophysin II gene in a family with autosomal dominant neurohypophyseal diabetes insipidus.
    Mundschenk J; Rittig S; Siggaard C; Hensen J; Lehnert H
    Exp Clin Endocrinol Diabetes; 2001; 109(8):406-9. PubMed ID: 11748489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A missense mutation in the vasopressin-neurophysin precursor gene cosegregates with human autosomal dominant neurohypophyseal diabetes insipidus.
    Bahnsen U; Oosting P; Swaab DF; Nahke P; Richter D; Schmale H
    EMBO J; 1992 Jan; 11(1):19-23. PubMed ID: 1740104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and molecular analysis of a Chinese family with autosomal dominant neurohypophyseal diabetes insipidus associated with a novel missense mutation in the vasopressin-neurophysin II gene.
    Luo Y; Wang B; Qiu Y; Zhang C; Jin C; Zhao Y; Zhu Q; Ma X
    Endocrine; 2012 Aug; 42(1):208-13. PubMed ID: 22307687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mutation in the coding region for neurophysin-II is associated with autosomal dominant neurohypophyseal diabetes insipidus.
    Rauch F; Lenzner C; Nürnberg P; Frömmel C; Vetter U
    Clin Endocrinol (Oxf); 1996 Jan; 44(1):45-51. PubMed ID: 8706292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Synonymous Variant in the AVP Gene Associated with Autosomal Dominant Familial Neurohypophyseal Diabetes Insipidus Causes Partial RNA Missplicing.
    Kvistgaard H; Christensen JH; Johansson JO; Gregersen N; Siggaard Rittig C; Rittig S; Corydon TJ
    Neuroendocrinology; 2018; 107(2):167-180. PubMed ID: 29949799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel mutant vasopressin-neurophysin II gene associated with familial neurohypophyseal diabetes insipidus.
    Miyakoshi M; Kamoi K; Murase T; Sugimura Y; Oiso Y
    Endocr J; 2004 Dec; 51(6):551-6. PubMed ID: 15644573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A missense mutation encoding Cys73Phe in neurophysin II is associated with autosomal dominant neurohypophyseal diabetes insipidus.
    Santiprabhob J; Browning J; Repaske D
    Mol Genet Metab; 2002; 77(1-2):112-8. PubMed ID: 12359138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.